13F Holdings
中文EN

BKYI BIO KEY INTERNATIONAL INC

Services-Prepackaged Software · Nasdaq · SEC CIK 1019034 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.0%
TTM net income YoY-40.1%
TTM EPS YoY—
Revenue 3-yr CAGR-4.8%
Net income 3-yr CAGR—

Margins

Gross margin84.4%
Operating margin-86.2%
Net margin-89.8%
FCF margin-67.5%
EBITDA margin-85.3%

Returns

ROE-94.7%
ROA-62.8%
ROIC (approx.)-108.5%
Asset turnover0.70x

Leverage & solvency

Liabilities / assets26.0%
Debt / equity0.00x
Current ratio2.47x
Interest coverage-129.12x

Cash quality & payout

Operating cash flow / net income0.75x
Accruals ratio-15.7%
Payout ratio—
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$5.94M$6.93M$7.75M$7.02M$5.11M
Cost of revenue$1.37M$1.29M$6.32M$2.44M$1.67M
Gross profit$4.56M$5.64M$1.43M$4.58M$3.44M
R&D expense$2.61M$2.51M$2.39M$3.25M$2.36M
SG&A expense$6.28M$7.14M$7.86M$9.36M$6.03M
Operating income-$6.83M-$4.01M-$8.83M-$9.92M-$4.94M
Interest expense$60,793$175,755$218,270$10,462$18,000
Pretax income-$7.14M-$4.32M-$8.66M-$11.93M$0
Income tax$16,500-$22,998-$134,014-$20,434$0
Net income-$7.16M-$4.30M-$8.52M-$11.91M-$5.07M
EBITDA-$6.74M-$3.92M-$8.75M-$9.88M-$4.89M
EPS (basic)-10.77-20.88-15.21-27.26-0.65
EPS (diluted)————-0.65
Weighted avg. shares (diluted)————7.79M
Balance sheet
Cash & equivalents$2.69M$437,604$511,400$2.64M$7.75M
Receivables$1.22M$718,229$1.20M$1.52M$970,626
Inventory$370,879$378,307$445,740$4.43M$4.94M
Current assets$4.54M$1.89M$2.62M$8.98M$14.01M
PP&E, net$67,751$140,198$220,177$107,413$69,168
Goodwill———$0$1.26M
Intangibles$830,357$1.10M$1.41M$1.76M$1.30M
Total assets$8.30M$8.62M$4.52M$11.34M$17.77M
Current liabilities$3.10M$4.55M$3.21M$5.46M$2.00M
Short-term debt——$138,730$120,000$0
Long-term debt—$44,762$188,787$326,767$0
Total debt—$44,762$327,517$446,767$0
Total liabilities$3.20M$4.84M$3.45M$6.04M$2.15M
Shareholders' equity$5.11M$3.77M$1.06M$5.30M$15.62M
Net debt—-$392,842-$183,883-$2.19M-$7.75M
Shares outstanding1.09M371,6961.03M552,7397.85M
Cash flow statement
Operating cash flow-$4.67M-$2.91M-$3.79M-$6.23M-$8.98M
Capital expenditure$12,012$13,047$1,000$82,040$42,024
Free cash flow-$4.68M-$2.93M-$3.79M-$6.31M-$9.02M
Investing cash flow-$12,012-$13,047-$1,000-$696,618-$42,024
Financing cash flow$6.91M$2.83M$1.43M$1.90M-$218,598
Depreciation & amortization$84,458$93,026$75,136$43,794$54,649
Stock-based compensation$166,575$243,250$265,732$387,907$314,715

Free plan shows the latest 5 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.